Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: juvenile idiopathic arthritis

Information on New Drug Approvals and Medication Safety

Michele B. Kaufman, PharmD, BCGP  |  March 8, 2012

Rheumatology-related drug safety, approvals, and what’s in the pipeline.

Filed under:Biologics/DMARDsConditionsDrug UpdatesGout and Crystalline Arthritis Tagged with:anti-inflammatoryBiologicscrystal arthritisdrugGoutJAK inhibitorsjanus kinaseMethotrexateRheumatoid arthritisrheumatologistSafetyTofacitinib

Data-Driven, Optimal Patient Care and Clinical Research

James R. O'Dell, MD  |  January 13, 2012

Expanded opportunities to advance rheumatology will be offered by ACR’s ongoing registry efforts

Filed under:Drug UpdatesEMRsInformation TechnologyLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/ImprovementResearch RheumTechnologyTechnology Tagged with:AC&RACAAdvocacyAffordable Care Act (ACA)American College of Rheumatology (ACR)drugelectronic health recordLegislationMedicarepatient carePQRSPractice ManagementResearchrheumatologistSafetyTechnology

Drug Updates: Apremilast, Belimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  January 13, 2012

Information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsBiologicsdrugJAK inhibitorsjanus kinaseMethotrexatePipelinePsoriatic ArthritisSafetySystemic lupus erythematosus

Old Drugs Can Learn New Tricks

Staff  |  November 1, 2011

Methotrexate and its mechanism of action

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AdenosineDrugsMethotrexateRARheumatoid arthritis

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2011

Information on new approvals and medication safety

Filed under:Drug Updates Tagged with:anti-inflammatoryApprovalsAutoimmuneDrugsFDAPipelineSafetytumor necrosis factor

Is It Time to Replace the HAQ?

Kathy Holliman  |  July 12, 2011

The PROMIS initiative uses item response theory to improve assessment of patient-reported health and wellbeing

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:Health Assessment Questionnaireoutcomepatient carerheumatologist

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 12, 2011

Information on New Approvals and Medication Safety

Filed under:AnalgesicsDrug Updates Tagged with:ApprovalsDrugsFDAPipelineSafety

CARRA

Mary Desmond Pinkowish  |  May 16, 2011

Working for Children with Rheumatic Diseases

Filed under:ConditionsOther Rheumatic ConditionsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:CARRAChildhood Arthritis and Rheumatology Research AllianceJIAJuvenile idiopathic arthritisLupusPediatric

New Guidance for Rheumatologists who Treat JIA

Kathy Hollimon, Med  |  April 13, 2011

Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Juvenile idiopathic arthritisResearchrheumatologistTreatment

A View of Industry from the Inside

Mary Pinkowish  |  April 13, 2011

Rheumatologists with pharmaceutical careers discuss the path that led them to industry and the work they do

Filed under:Career DevelopmentProfessional TopicsWorkforce Tagged with:Career developmentIndustryrheumatologist

  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 37
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences